General Prognostics
PrivateLast Round
Seed
Nov 12, 2024
Total Funding Raised
$3.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
General Prognostics is a healthcare technology company that provides an AI-based platform for remote chronic disease management through bloodless blood tests.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Health IoT, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
General Prognostics Comparables
Compare General Prognostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bodyport | 78% | |
| Myia Health | 78% | |
| AIKON Health | 77% | |
General Prognostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 12, 2024 | ||||
| Seed | Sep 30, 2022 |
General Prognostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NEC X | Seed |
| D4V (Design for Ventures) | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors grew 115% MoM, from 2.3K to 5K.
General Prognostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about General Prognostics's valuation, stock price, and market status.